A clinical and scientific examination of Narrow Band Imaging (NBI) technology in bladder cancer management. Dr. Bochner details the biophysical mechanism of NBI, focusing on how the 415 nm and 540 nm wavelengths match hemoglobin absorption to highlight vascularization. The session reviews key clinical trial data on tumor detection sensitivity and showcases real cystoscopic comparisons of papillary and flat (CIS) lesions under white light versus NBI.
Share it with your network and help spread clinical knowledge.
